Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics

from The BioHub: The Top Voices in Biotech · host Max Brennan - Biotech HeadHunter

In our first JPM Special 2026, we’re joined by Dirk Thye, CEO of Quince Therapeutics, as the company approaches a defining Phase 3 readout. A candid conversation about high-stakes data, leadership under pressure, and what a true do-or-die moment looks like in biotech.

Episode metadata supplied by the publisher feed · Published Jan 26, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics

0:00 11:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The BioHub: The Top Voices in Biotech?

This episode is 11 minutes long.

When was this The BioHub: The Top Voices in Biotech episode published?

This episode was published on January 26, 2026.

Can I download this The BioHub: The Top Voices in Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!